1. Introduction {#sec1-microorganisms-08-00136}
===============

Since the 1980s, a concerning decrease in semen quality has been reported, and potential causes are still being debated \[[@B1-microorganisms-08-00136],[@B2-microorganisms-08-00136]\]. Etiologies, including endocrine and genetic disorders, have been demonstrated \[[@B3-microorganisms-08-00136]\], but male infertility may be linked to environmental factors. Lifestyle habits, such as smoking, high BMI, and the increasing exposure to xenoestrogens, for example in drinking water, have been associated with reduced male fertility \[[@B4-microorganisms-08-00136],[@B5-microorganisms-08-00136]\]. An additional hypothesis is that silent and/or chronic bacterial infections of the genital tract causing inflammation and direct deterioration of semen might partially explain some of the otherwise idiopathic cases \[[@B3-microorganisms-08-00136],[@B6-microorganisms-08-00136],[@B7-microorganisms-08-00136],[@B8-microorganisms-08-00136]\]. The well-known intracellular pathogen, *Chlamydia trachomatis*, which can cause urethritis and negatively impact spermatozoa physiology, may be a key example \[[@B9-microorganisms-08-00136],[@B10-microorganisms-08-00136],[@B11-microorganisms-08-00136],[@B12-microorganisms-08-00136]\].

Using an in vitro model of infection, we recently showed that *Waddlia chondrophila*, an emerging *Chlamydia*-like bacterium, has a negative impact on human spermatozoa \[[@B13-microorganisms-08-00136]\]. By analogy with *C. trachomatis*, *W. chondrophila* was able to attach and penetrate into spermatozoa, reducing their viability and mitochondrial membrane potential, which is linked to motility. Moreover, standard sperm washing techniques were unable to completely eradicate it.

*W. chondrophila* was first isolated from samples of aborted bovine fetuses \[[@B14-microorganisms-08-00136],[@B15-microorganisms-08-00136]\]. This raised concerns for a potential abortigenic agent for other mammals, including humans. Three independent prospective serology based studies indicated that *W. chondrophila* might act as a possible inducer of miscarriage in pregnant women \[[@B16-microorganisms-08-00136],[@B17-microorganisms-08-00136],[@B18-microorganisms-08-00136]\]. Moreover, *W. chondrophila* was shown to replicate in several human cell lines including fibroblasts, peripheral blood mononuclear cells, A549 pneumocytes, and in Ishikawa endometrial cells \[[@B14-microorganisms-08-00136],[@B19-microorganisms-08-00136],[@B20-microorganisms-08-00136]\]. The seroprevalence of anti-*W. chondrophila* antibodies was significantly higher in women who experienced miscarriages compared to control groups of women with uneventful pregnancies. This association remained significant even after correction for age, ethnicity, and *C. trachomatis* serology status and was not due to cross-reactivity with other microorganisms known to induce pregnancy loss, such as *C. trachomatis*, *Coxiella burnetti*, *Toxoplasma gondii*, *Brucella abortus*, and *Parachlamydia acanthamoebae* \[[@B16-microorganisms-08-00136]\]. Presence of *W. chondrophila* in human samples (placenta, vaginal swab, urine) was subsequently documented by PCR and/or immunohistochemistry \[[@B17-microorganisms-08-00136]\].

Despite multiple reports of association with adverse pregnancy outcomes and the negative effect on human spermatozoa, it is not known whether *W. chondrophila* is associated with a deleterious effect on the male genital tract. This study aims to analyze whether this bacterium could be linked with reproductive disorders in men, namely men of infertile couples.

2. Material and Methods {#sec2-microorganisms-08-00136}
=======================

2.1. Samples {#sec2dot1-microorganisms-08-00136}
------------

Serum and sperm samples were collected from men of infertile couples seeking infertility investigations at the Fertility Medicine Unit (Lausanne University Hospital, Lausanne, Switzerland). This study was carried out in accordance with the recommendations of the Cantonal Human Research Ethics Commission of Vaud (CER-VD)( protocol 265/14), according to the Swiss Federal Act on Research involving Human Beings. The study protocol was approved by the commission (protocol 265-14). All patients were fully informed about the content of the research project and gave their written consent to be included in the study.

Semen assessment was performed in the Laboratory of Andrology and Reproductive Biology (LABR, Lausanne University Hospital, Switzerland). Semen was obtained by masturbation after 2 to 5 days of sexual abstinence. After a 30 min liquefaction at 37 °C, samples were manually assessed for volume, pH, and morphology using the Papanicolaou method. CASA SCA (Version 5.4, Microptic SL, Barcelona, Spain) computer-assisted sperm analysis software was used to evaluate sperm concentration and motility (total and progressive). All analyses were performed following the 2010 World Health Organization laboratory manual for the examination and processing of human semen guidelines (5th edition).

2.2. Microimmunofluorescence {#sec2dot2-microorganisms-08-00136}
----------------------------

Serology for *W. chondrophila* was performed as described previously \[[@B16-microorganisms-08-00136],[@B21-microorganisms-08-00136]\]. Briefly, formalin-inactivated *W. chondrophila* strain ATCC VR-1470 was deposited on serology slides as an antigen. Serum samples were serially diluted in phosphate-buffered saline, and dilutions of 1/32 and 1/64 were included in the analysis. Mouse anti-human IgG secondary antibody conjugated to Alexa Fluor 488 dye (Thermo Fisher Scientific, Allschwil, Switzerland, diluted 1/1000) was used to detect the presence of anti-*W. chondrophila* IgG.

Microimmunofluorescence tests were analyzed by two independent evaluators. Weighted Cohen's kappa coefficient was determined for each series to assess the agreement of the results and always ranked between "good" and "very good". In cases of discrepancy, a third evaluator was involved, and the case was discussed to reach consensus.

2.3. Enzyme-Linked Immunosorbent Assay (ELISA) {#sec2dot3-microorganisms-08-00136}
----------------------------------------------

Serology for *C. trachomatis* was performed with the "Anti-*Chlamydia trachomatis* ELISA (IgG)" (EI 2191-9601 G, EUROIMMUN Schweiz AG, Luzern, Switzerland), according to the manufacturer's indications.

2.4. DNA Extraction from Sperm Samples and Real-Time Quantitative Polymerase Chain Reaction Assay (qPCR) {#sec2dot4-microorganisms-08-00136}
--------------------------------------------------------------------------------------------------------

DNA was extracted from 1 mL of semen using the QIAamp DNA mini kit (Qiagen AG, Basel, Switzerland) following the manufacturer's specifications with the addition of 43 mM DTT to the lysis buffer as the sole modification. All samples were analyzed using a *W. chondrophila*-specific qPCR and a Chlamydiales-specific qPCR, as previously described \[[@B22-microorganisms-08-00136],[@B23-microorganisms-08-00136]\].

2.5. DNA Sequencing and Analysis {#sec2dot5-microorganisms-08-00136}
--------------------------------

DNA sequencing was performed by Eurofins Genomics (Eurofins Genomics GmbH, Kostanz, Germany), with the primers used for the Chlamydiales-specific qPCR \[[@B23-microorganisms-08-00136]\]. Obtained sequences were manually trimmed and blasted against the NCBI nr/nt database (partially non-redundant nucleotide sequences from GenBank, EMBL, and DDB, analysis performed on September 2019) using the blast module of the Geneious prime software (version 2020.1, Biomatters Limited, Auckland, New Zealand). For each positive sample, the top hit from the blast analysis was presented in [Table 1](#microorganisms-08-00136-t001){ref-type="table"}.

2.6. Statistical Analysis {#sec2dot6-microorganisms-08-00136}
-------------------------

Statistical analysis was performed with RStudio Version 1.2.1335 (RStudio, Inc., Boston, MA, USA). Categorical variables were compared using the Pearson χ2 test, while continuous variables were compared using the Wilcoxon--Mann--Whitney test. A *p*-value \< 0.05 was considered statistically significant.

3. Results {#sec3-microorganisms-08-00136}
==========

A total of 204 men of infertile couples were enrolled in the study, and their semen parameters were evaluated using the WHO guidelines. The impact of *W. chondrophila* on semen parameters was assessed by performing serological analysis on the serum samples. A total of 58.3% of patients had *W. chondrophila*-specific IgG, indicating a previous exposure to the microorganism. Our results indicated that positive serology was not significantly associated with abnormal semen status ([Table 2](#microorganisms-08-00136-t002){ref-type="table"} and [Table 3](#microorganisms-08-00136-t003){ref-type="table"}). In addition, seropositivity was not linked to a reduced value of specific spermiogram parameters, including total spermatozoa count and concentration, total motility, progressive motility, and morphology ([Table 2](#microorganisms-08-00136-t002){ref-type="table"}). Similar results were observed for *C. trachomatis*, although seroprevalence was lower in this case ([Table 2](#microorganisms-08-00136-t002){ref-type="table"}). Interestingly, we observed an association with patient age, as the group with positive serology (1/32) was significantly older compared to men with negative serology ([Table 2](#microorganisms-08-00136-t002){ref-type="table"}).

Given the high exposure to the bacterium, we wanted to evaluate whether *W. chondrophila* actively colonizes sperm of patients included in the study. Total DNA was extracted from semen samples and analyzed with a specific qPCR, which indirectly shows presence of the bacteria in the sample. None of the samples tested positive for *W. chondrophila* DNA. For this reason, we did not attempt the isolation of the bacterium from semen.

To analyze the presence of *Chlamydia*-like bacteria more broadly, samples were additionally tested with a Chlamydiales-specific qPCR. A total of 2.9% (*n* = 6) of samples were positive with qPCR analysis, and their amplified DNA was purified, sequenced, and compared to sequences present in nucleotide sequence databases. Top hits obtained by blast analysis with the highest identity and alignment lengths are shown in [Table 1](#microorganisms-08-00136-t001){ref-type="table"}. Interestingly, five of these six patients had abnormal semen parameters.

4. Discussion {#sec4-microorganisms-08-00136}
=============

Multiple serological studies have demonstrated an association of the intracellular bacterium *W. chondrophila* with adverse pregnancy outcomes. Most studies have targeted female patients, while seroprevalence of *W. chondrophila* in men has only been investigated on two occasions, until now. In the first study, 13.7% of healthy young Swiss men (66 out of 482) attending military service tested positive \[[@B24-microorganisms-08-00136]\], while in the second, this was the case for 45% (18 out of 40) of Israeli men \[[@B25-microorganisms-08-00136]\].

We have previously shown that human spermatozoa exposed to *W. chondrophila* displayed a reduction of viability and mitochondrial membrane potential \[[@B13-microorganisms-08-00136]\]. Therefore, this study focused on a population of men of infertile couples in order to address whether exposure to this bacterium negatively impacts male fertility.

Interestingly, we observed a high seroprevalence of 58.3%, which is higher compared to all previous serology studies, including those with women who experienced adverse pregnancy outcomes \[[@B16-microorganisms-08-00136],[@B17-microorganisms-08-00136],[@B18-microorganisms-08-00136]\]. On the contrary, we did not detect *W. chondrophila* DNA, indicating that this bacterium might not colonize semen. The high seroprevalence and absence by qPCR detection may be explained by multiple scenarios. For example, (a) infection may have occurred in the past, and thus the qPCR is negative; (b) the infection is ongoing, but in a body site other than the male reproductive system; (c) the infection occurred in the past in another body site.

One important limitation of our study is the absence of a control population consisting of men with proven fertility, which was not explored due to ethical aspects and the difficulty of obtaining semen in healthy individuals. Moreover, we cannot rule out the presence of PCR inhibitors in DNA extracted from semen, which could inhibit the *W. chondrophila*-specific qPCR. Nevertheless, our previous study showed that this bacterium could be detected within artificially infected sperm samples by the same qPCR \[[@B13-microorganisms-08-00136]\].

Similar studies performed with *C. trachomatis*, which was also included in our study, gave highly variable outcomes \[[@B26-microorganisms-08-00136],[@B27-microorganisms-08-00136],[@B28-microorganisms-08-00136]\]. It is still not clear if and how *C. trachomatis* impacts male fertility, although it can cause epididymitis, urethritis, and prostatitis, all of which might lead to an impairment of reproductive potential \[[@B3-microorganisms-08-00136],[@B29-microorganisms-08-00136]\]. Moreover, it can have a direct negative effect on spermatozoa physiology \[[@B10-microorganisms-08-00136],[@B30-microorganisms-08-00136],[@B31-microorganisms-08-00136],[@B32-microorganisms-08-00136]\], as shown in vitro for *W. chondrophila* \[[@B13-microorganisms-08-00136]\]. In the present clinical study, we did not observe any significant association with abnormal semen parameters in males that tested positive for *W. chondrophila*. Male seropositivity was not associated with adverse pregnancy outcomes such as miscarriage in their female partners.

Although we did not find *W. chondrophila* in the semen of patients included in this study, we detected the presence of Chlamydiales DNA in 2.4% of samples (*n* = 6). Of note, the majority of these patients (*n* = 5), had abnormal spermiograms. Given that the detected sequences belonged to previously uncultured Chlamydiales, the role of these isolates in semen colonization warrants further investigation, including isolation and assessment of the impact on spermatozoa physiology.

Interestingly, *W. chondrophila* serology was significantly higher in patients above the age of 30, meaning that the risk of infection may increase with age. Compared to our previous study on healthy Swiss males, in which the mean age was 20.6 ± 1.4 and *W. chondrophila* seropositivity was 13.7% \[[@B24-microorganisms-08-00136]\], the high seroprevalence observed in men of infertile couples may suggest a deleterious immunological role of *W. chondrophila* on male fertility. Similarly to what has been described earlier \[[@B21-microorganisms-08-00136]\], the immunological response against *W. chondrophila* may involve the induction of an autoimmune response against an epitope shared by the bacteria and spermatozoa/ova antigens. Alternatively, a transient negative effect on male infertility may be observed only during an ongoing infection.

Overall, the high *W. chondrophila* seroprevalence indicates frequent exposure of men to this bacterium in Western Switzerland. Therefore, further studies are required to understand the impact of this bacterium on human health.
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microorganisms-08-00136-t001_Table 1

###### 

Chlamydiales bacteria detected in the semen samples.

  Sample   Hit                                                    Accession Number   Identity (%)   Alignment Length (bp)   *W. chondrophila* Serology   *C. trachomatis* Serology   Spermiogram
  -------- ------------------------------------------------------ ------------------ -------------- ----------------------- ---------------------------- --------------------------- -------------
  1        Uncultured Chlamydiales bacterium clone 14-41          KX451108           96.8           156                     Pos                          Neg                         Abnormal
  7        Uncultured Chlamydiales bacterium clone 12-15          KX451048           95.7           162                     Pos                          Neg                         Abnormal
  10       Uncultured Chlamydiales bacterium clone 14-02          JX083073           91.4           175                     Pos                          Neg                         Abnormal
  135      Uncultured Chlamydiales bacterium clone HE210001biof   JX083106           94.9           78                      Pos                          Neg                         Normal
  222      Uncultured Chlamydiales bacterium clone AHDr12         JQ860021           100            181                     Pos                          Neg                         Abnormal
  239      Uncultured Chlamydiales bacterium clone AHDr12         JQ860021           100            181                     Pos                          Neg                         Abnormal

microorganisms-08-00136-t002_Table 2

###### 

Characteristics of patients according to *W. chondrophila* serology.

  Characteristics                    *W. chondrophila* Serology 1/32   *W. chondrophila* Serology 1/64                                     
  ---------------------------------- --------------------------------- --------------------------------- ------- ------------ ------------ -------
  **Demographic characteristics**                                                                                                          
  Age (years)                        35.9 ± 7.0                        38.0 ± 6.1                        0.005   36.9 ± 7.2   37.4 ± 5.8   0.322
    \<30                             20                                11                                0.005   20           11           0.185
    \>30                             65                                108                                       86           87           
  Origin                                                                                                                                   
    Swiss                            39                                58                                0.687   52           45           0.758
    Non-swiss                        46                                61                                        54           53           
  Origin partner                                                                                                                           
    Swiss                            33                                38                                0.308   41           30           0.289
    Non-swiss                        52                                81                                        65           68           
  Education                                                                                                                                
    University                       21                                29                                0.956   28           22           0.621
    Non-university                   64                                90                                        78           76           
  Place of residence                                                                                                                       
    City                             66                                81                                0.133   77           70           0.971
    Rural                            19                                38                                        29           28           
  Pets                                                                                                                                     
    Yes                              26                                38                                0.838   36           28           0.498
    No                               59                                81                                        70           70           
  **Serology (IgG)**                                                                                                                       
  *C. trachomatis* serology                                                                                                                
    Neg                              72                                98                                0.657   88           82           0.950
    Pos                              13                                21                                        18           16           
  **Semen characteristics**                                                                                                                
  Spermiogram                                                                                                                              
    Normal                           18                                29                                0.593   24           23           0.888
    Abnormal                         67                                90                                        82           75           
  Sperm concentration (× 10^6^/mL)                                                                                                         
    Mean                             37.53                             39.88                             0.862   38.59        39.24        0.815
    SD                               42.85                             39.48                                     41.69        40.09        
  Total sperm count (× 10^6^)                                                                                                              
    Mean                             112.06                            116.31                            0.867   109.7        119.77       0.879
    SD                               115.75                            122.11                                    110.26       128.6        
  Total motility (%)                                                                                                                       
    Mean                             53.44                             52.69                             0.841   52.82        53.19        0.864
    SD                               23.22                             23.74                                     23.45        23.6         
  Progressive motility (%)                                                                                                                 
    Mean                             37.65                             36.44                             0.775   37.26        36.59        0.992
    SD                               18.77                             18.12                                     18.86        17.88        
  Sperm morphology (%)                                                                                                                     
    Mean                             2.52                              2.91                              0.343   2.61         2.89         0.546
    SD                               2.27                              2.51                                      2.31         2.53         
  **Clinical history**                                                                                                                     
  Andrological issues                                                                                                                      
    Yes                              9                                 13                                0.939   11           11           0.845
    No                               76                                106                                       95           87           
  Obstetrical issues (partner)                                                                                                             
    Yes                              35                                37                                0.137   44           28           0.074
    No                               50                                82                                        62           70           
  Miscarriages (partner)                                                                                                                   
    Yes                              32                                32                                0.103   39           25           0.241
    No                               53                                87                                        67           73           

microorganisms-08-00136-t003_Table 3

###### 

Characteristics of patients according to semen parameters.

  Characteristics                    Sperm Parameters                
  ---------------------------------- ------------------ ------------ ---------
  **Demographic characteristics**                                    
  Age (years)                        37.2 ± 7.2         37.1 ± 6.4   0.899
    \<30                             8                  23           0.691
    \>30                             39                 134          
  Origin                                                             
    Swiss                            30                 67           0.011
    Non-swiss                        17                 90           
  Origin partner                                                     
    Swiss                            20                 51           0.204
    Non-swiss                        27                 106          
  Education                                                          
    University                       15                 35           0.179
    Non-university                   32                 122          
  Place of residence                                                 
    City                             36                 111          0.429
    Rural                            11                 46           
  Pets                                                               
    Yes                              17                 47           0.419
    No                               30                 110          
  **Serology**                                                       
  *W. chondrophila* serology                                         
    Neg                              18                 67           0.593
    Pos                              29                 90           
  *C. trachomatis* serology                                          
    Neg                              37                 133          0.334
    Pos                              10                 24           
  **Semen characteristics**                                          
  Sperm concentration (× 10^6^/mL)                                   
    Mean                             80.43              26.47        \<0.001
    SD                               43.43              30.63        
  Total perm count (× 10^6^)                                         
    Mean                             231.69             79.47        \<0.001
    SD                               123.05             93.06        
  Total motility (%)                                                 
    Mean                             75.77              46.18        \<0.001
    SD                               12.02              21.71        
  Progressive motility (%)                                           
    Mean                             54.85              31.58        \<0.001
    SD                               11.55              16.54        
  Sperm morphology (%)                                               
    Mean                             5.47               1.93         \<0.001
    SD                               1.8                1.93         
  **Clinical history**                                               
  Andrological issues                                                
    Yes                              5                  17           0.971
    No                               42                 140          
  Obstetrical issues (partner)                                       
    Yes                              20                 52           0.235
    No                               27                 105          
  Miscarriages (partner)                                             
    Yes                              31                 109          0.653
    No                               16                 48           

[^1]: Shared first authorship.
